Feline Spirochaeta antibody and antigen (recombinant protein)
Diagnostic anti-Feline Spirochaeta antibodies pairs and antigen for animal health (animal Cat/Feline) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-Spirochaeta-Ag01 | Recombinant Feline Spirochaeta protein | 3090 |
GMP-FEL-Spirochaeta-Ab01 | Anti-Feline Spirochaeta mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-Spirochaeta-Ab02 | Anti-Feline Spirochaeta mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-Spirochaeta-Ab03 | Anti-Feline Spirochaeta human monoclonal antibody (mAb) | 1953 |
GMP-FEL-Spirochaeta-Ab04 | Anti-Feline Spirochaeta human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-Spirochaeta-Ag01 |
Product Name | Recombinant Feline Spirochaeta protein |
Target/Biomarker | Feline Spirochaeta () |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline Spirochaeta antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Cat/Feline with N/A. |
Tag | His |
Products description | Recombinant Feline Spirochaeta protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-Spirochaeta-Ab01, GMP-FEL-Spirochaeta-Ab02 |
Product Name | Anti-Feline Spirochaeta mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline Spirochaeta () |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline Spirochaeta antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Cat/Feline with N/A. |
Tag | mFc |
Products description | Anti-Feline Spirochaeta mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-Spirochaeta-Ab03, GMP-FEL-Spirochaeta-Ab04 |
Product Name | Anti-Feline Spirochaeta human monoclonal antibody (mAb) |
Target/Biomarker | Feline Spirochaeta () |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Feline Spirochaeta antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Cat/Feline with N/A. |
Tag | hFc |
Products description | Anti-Feline Spirochaeta human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Spirochetes are a group of motile bacteria, characterized by their unique helical shape, which allows them to move in a corkscrew motion. In cats (felines), spirochetes can be associated with various health conditions, although they are not as commonly reported in cats as in other species. One of the more well-known spirochetal infections in animals and humans is caused by the Borrelia species, which is responsible for Lyme disease, but direct involvement in feline health with this particular spirochete is relatively rare due to cats' apparent resistance to Lyme disease symptoms. Common Spirochetal Infections in Cats Leptospirosis: While leptospirosis is primarily known to affect dogs, cats can also be exposed to Leptospira spp., the bacteria responsible for this disease. However, cats often appear to be resistant to leptospirosis, or they may be asymptomatic carriers. The disease in mammals generally causes kidney and liver issues, but confirmed cases in cats are rare, and they are not considered a major reservoir for the bacteria. Periodontal Disease: Certain spirochetes have been implicated in periodontal disease in cats, as part of the complex bacterial community that contributes to oral infections. These bacteria can contribute to the plaque that leads to gingivitis and periodontitis. Diagnosis and Treatment Diagnosis: Diagnosing spirochetal infections in cats can involve serological tests, PCR (Polymerase Chain Reaction) assays, and microscopic examination of samples from affected tissues. For periodontal disease, a clinical examination supported by dental X-rays can help identify the extent of the problem. Treatment: Treatment for spirochetal infections may include antibiotics that are effective against these types of bacteria. For leptospirosis, although rare in cats, supportive care and treatment with appropriate antibiotics can be effective. Managing periodontal disease involves dental cleaning, possibly under anesthesia, and may require tooth extractions in severe cases. Prevention Preventive measures for spirochetal infections include controlling exposure to environments where leptospirosis could be contracted (more relevant for dogs than cats) and maintaining good oral hygiene to prevent periodontal disease. Regular veterinary check-ups are important for early detection and management of these and other health issues. In summary, while spirochetes can affect cats, the impact and prevalence of specific spirochetal diseases like leptospirosis are less significant in cats than in other animals. Nonetheless, awareness of the potential for these infections and proper veterinary care can help manage and prevent health issues associated with spirochetes in feline populations.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.